摘要
尽管许多基因突变和分子机制被认为参与了肌萎缩侧索硬化症(ALS),但是如此严重的神经退行性紊乱仍然缺乏实质性治疗。本文不是对潜在治疗方法进行概述,而是侧重关注新颖的分子机制的新研究发现,创新的分子机制在发展未来的ALS疗法中显示一定前景。本文中特别强调了自我吞噬状态和在错误折叠蛋白形成中聚合的那些自我吞噬基质。实际上,就如本文第一部分概述,家族ALS症的多数的基因突变中会发生自我吞噬通路变异。这些突变减少自我吞噬基质的清除,从而导致巨大的变异线粒体和错误折叠蛋白的积聚。因此,这篇综述主要致力于介绍错误折叠蛋白非常规加工导致的非正常的蛋白质类分泌物,该分泌物可能构成ALS神经病理学在细胞间扩散的一种成分。为了了解未来研究中的潜在治疗靶点,对调节这些步骤的重要机制进行了分析。同时,鉴于新型疾病致病机制,关于最近实验的阴性结果我们也进行了解释。在本章的最后一部分,我们讨论了与脊髓和相关运动区域的细胞间壁操作毒性机制相关的局灶性干细胞移植替代疗法。
关键词: 糖基化终产物(AGEs);肌萎缩侧索硬化症(ALS);自我吞噬;错误折叠蛋白;线粒体;prionoids;闰绍细胞;干细胞疗法
Current Medicinal Chemistry
Title:Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease
Volume: 21 Issue: 31
Author(s): Livia Pasquali, Paola Lenzi, Francesca Biagioni, Gabriele Siciliano and Francesco Fornai
Affiliation:
关键词: 糖基化终产物(AGEs);肌萎缩侧索硬化症(ALS);自我吞噬;错误折叠蛋白;线粒体;prionoids;闰绍细胞;干细胞疗法
摘要: Despite a number of genetic mutations and molecular mechanisms are recognized to participate in amyotrophic lateral sclerosis (ALS), such a devastating neurological disorder still lacks a substantial cure. The present manuscript rather than a general overview of potential therapeutic approaches focuses on novel research findings detailing novel molecular mechanisms which appear to be promising for developing future ALS therapeutics. A special emphasis is given to the abnormal autophagy status and to those autophagy substrates which aggregate in the form of misfolded proteins. In fact, as reviewed in the first part of the manuscript, altered autophagy pathway is present in most genetic mutations responsible for familial ALS. These mutations impair clearance of autophagy substrates, which determines accumulation of giant altered mitochondria and misfolded proteins. Therefore, a considerable piece of the review is dedicated to unconventional processing of misfolded proteins leading to unconventional protein secretions which may underlie a prionoid cell to- cell spreading of ALS neuropathology. The intimate mechanisms regulating these steps are analyzed in order to comprehend which potential therapeutic targets might be considered in future studies. At the same time, negative findings concerning recent trials are explained in light of novel disease mechanisms. In the final part of the review the replacement therapy with focal stem cells implantation is discussed in relationship with toxic mechanisms operating in the intercellular space of the spinal cord and motor-related areas.
Export Options
About this article
Cite this article as:
Pasquali Livia, Lenzi Paola, Biagioni Francesca, Siciliano Gabriele and Fornai Francesco, Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease, Current Medicinal Chemistry 2014; 21 (31) . https://dx.doi.org/10.2174/0929867321666140601161534
DOI https://dx.doi.org/10.2174/0929867321666140601161534 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological and Clinical Basis of Treatment of Familial Mediterranean Fever (FMF) with Colchicine or Analogues: An Update
Current Drug Targets - Inflammation & Allergy Respiratory Tract Manifestations of Rheumatic Diseases in Children
Current Respiratory Medicine Reviews Therapeutic Apheresis in Metabolic Syndrome
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Anti-VEGF Treatment in Corneal Diseases
Current Drug Targets Studies on Novel Pyridine and 2-pyridone Derivatives of N-arylpiperazine as α-adrenoceptor Ligands
Medicinal Chemistry Cytostatic Properties of Some Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type I Receptor Antagonists
Current Pharmaceutical Design Intravenous Immunoglobulin as a Potential Therapy for Refractory Urticaria - A Review
Inflammation & Allergy - Drug Targets (Discontinued) Increased Pulmonary Heme Oxygenase-1 and δ-Aminolevulinate Synthase Expression in Monocrotaline-Induced Pulmonary Hypertension
Current Neurovascular Research Anti-Tumor Monoclonal Antibodies in Conjunction with β-Glucans: A Novel Anti- Cancer Immunotherapy
Current Medicinal Chemistry Role of Redox Homeostasis and Inflammation in the Pathogenesis of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Current Molecular Medicine Ipilimumab Targeting CD28-CTLA-4 Axis: New Hope in the Treatment of Melanoma
Current Topics in Medicinal Chemistry The Diterpenoids of the Genus Elaeoselinum (Apiaceae) and their Biological Properties
Current Organic Chemistry A Systematic Approach to Hypertensive Urgencies and Emergencies
Current Hypertension Reviews Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?
Current Pharmaceutical Design Mechanisms of Inflammatory Atherosclerosis in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Nerve Growth Factor in Neurological and Non-Neurological Diseases: Basic Findings and Emerging Pharmacological Prospectives
Current Pharmaceutical Design Glyco-Engineering of Human IgG-Fc to Modulate Biologic Activities
Current Pharmaceutical Biotechnology Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design The Antioxidant Effects of Radix Astragali (Astragalus membranaceus and Related Species) in Protecting Tissues from Injury and Disease
Current Drug Targets